nalidixic acid has been researched along with Protein-Losing Enteropathies in 1 studies
Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, AN | 1 |
| Sarker, SA | 1 |
| Wahed, MA | 1 |
| Khatun, M | 1 |
| Rahaman, MM | 1 |
1 trial available for nalidixic acid and Protein-Losing Enteropathies
| Article | Year |
|---|---|
Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation.
Topics: Cell Membrane Permeability; Child; Child, Preschool; Double-Blind Method; Dysentery, Bacillary; Fema | 1994 |